Exact Sciences (EXAS) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
Mizuho Securities Downgrades Exact Sciences (EXAS) to Neutral
May 4, 2016 6:29 AM EDTMizuho Securities downgraded Exact Sciences (NASDAQ: EXAS) from Buy to Neutral with a price target of $6.50 (from $12.00).
Analyst Eric Criscuolo commented, "Were downgrading EXAS from Buy to Neutral and lowering our PT from $12 to $6.50. We now see too much risk to test... More



